» Authors » Sandra Steffens

Sandra Steffens

Explore the profile of Sandra Steffens including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 611
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Mikuteit M, Zschabitz S, Stohr C, Herrmann E, Polifka I, Agaimy A, et al.
Urol Int . 2023 Jun; 107(7):713-722. PMID: 37348477
Introduction: Growth arrest-specific protein 6 (Gas 6) is a ligand that plays a role in proliferation and migration of cells. For several tumor entities, high levels of Gas 6 are...
12.
Schroder D, Muller F, Heesen G, Hummers E, Dopfer-Jablonka A, Vahldiek K, et al.
PLoS One . 2023 May; 18(5):e0286014. PMID: 37228048
Background/aims: The COVID-19 pandemic situation poses new challenges for research. Ethical issues might arise if especially vulnerable individuals for severe COVID-19 course expose themselves because of participation in studies to...
13.
Erlmeier M, Mikuteit M, Zschabitz S, Autenrieth M, Weichert W, Hartmann A, et al.
BMC Urol . 2023 May; 23(1):90. PMID: 37170275
Background: The prognostic value of Hepatocyte growth factor (HGF) in non-clear cell renal cell carcinoma (RCC) is still unclear. The aim of this study is to evaluate the prognostic impact...
14.
Niewolik J, Mikuteit M, Schroder D, Heinemann S, Heesen G, Muller F, et al.
Dermatologie (Heidelb) . 2023 Jan; 74(2):108-113. PMID: 36645432
Background: Measures used to contain the spread of coronavirus disease 2019 (COVID-19) have impaired the social participation of many people. Especially people with chronic or oncologic conditions were affected. In...
15.
Zschabitz S, Mikuteit M, Stohr C, Herrmann E, Polifka I, Agaimy A, et al.
Discov Oncol . 2022 Sep; 13(1):90. PMID: 36136143
Background: Nectin-4 contributes to tumor proliferation, lymphangiogenesis and angiogenesis in malignant tumors and is an emerging target in tumor therapy. In renal cell carcinoma (RCC) VEGF-directed tyrosine kinase inhibitors and...
16.
Erlmeier F, Zschabitz S, Mikuteit M, Autenrieth M, Weichert W, Hartmann A, et al.
Histol Histopathol . 2022 Sep; 38(4):403-407. PMID: 36128931
Background: The prognostic value of Claudin-6 (CLDN6) in non clear cell renal cell carcinoma (RCC) is still unclear. Aim: To evaluate the prognostic impact of CLDN6 expression in a large...
17.
Mikuteit M, Heinemann S, Roder S, Niewolik J, Schroder D, Vahldiek K, et al.
JMIR Res Protoc . 2022 Sep; 11(10):e38718. PMID: 36108134
Background: With population-wide vaccination availability, the global COVID-19 pandemic entered a new phase. Despite vaccination status, some people who were infected with SARS-CoV-2 experience long-term symptoms. Objective: In this study,...
18.
Homann S, Mikuteit M, Niewolik J, Behrens G, Stolting A, Muller F, et al.
Int J Environ Res Public Health . 2022 Aug; 19(16). PMID: 36011559
Background: Patients who are post-COVID-19 will require more treatment soon. Therefore, it is important to understand the root cause of their psychological and somatic conditions. Previous studies showed contradictory results...
19.
Mikuteit M, Zschabitz S, Erlmeier M, Autenrieth M, Weichert W, Hartmann A, et al.
Oncology . 2022 Jun; 100(10):536-541. PMID: 35760058
Background: Overexpression of tumor-associated growth arrest-specific protein 6 (Gas6) is found in many tumor entities. The prognostic value of Gas6 in renal cell carcinoma (RCC), especially in non-clear cell RCC,...
20.
Heesen G, Schroder D, Muller F, Hummers E, Klawonn F, Mikuteit M, et al.
Front Public Health . 2022 Jun; 10:877623. PMID: 35757603
Immunocompromised persons are at an increased risk for a severe SARS-CoV-2 infection and their safety behaviors may influence their social participation. Vaccinated persons have a lower incidence of infection and...